ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,012.28
      -1.46%
      US Tech 100
      20,580.00
      -2.86%
      Dow Jones
      44,713.58
      0.65%
      Brent Oil
      76.255
      -0.02%
      Bitcoin
      102,416.00
      0.34%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE

      6. Aim Immunotech Inc (0A4Y) Quote

      Aim Immunotech Inc

      Aim Immunotech Inc (0A4Y)

      LSE
      0.00
      0.00
      (0.00%)
      Closed January 27 11:30AM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      -
      Bid
      0.00
      Ask
      0.00
      Volume
      96
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Market Cap
      -
      Previous Close
      0.00
      Open
      -
      Last Trade
      89
      @
      0.2105
      (O)
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      48,842,000
      Dividend Yield
      -
      PE Ratio
      -3.04
      Earnings Per Share (EPS)
      -0.59
      Revenue
      202k
      Net Profit
      -28.96M

      About Aim Immunotech Inc

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.aimimmuno.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Aim Immunotech Inc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker 0A4Y. The last closing price for Aim Immunotech was $0. Over the last year, Aim Immunotech shares have traded in a share price range of $ 0.00 to $ 0.00.

      Aim Immunotech currently has 48,842,000 shares outstanding. Aim Immunotech has a price to earnings ratio (PE ratio) of -3.04.

      Ask ADVFN Intelligence (AI)

      0A4Y Latest News

      More News

      FeaturedLaFleur Minerals Provides Updates on Exploration at Swanson Gold Deposit and Plans to Restart of Beacon Gold Mill

      13 hours ago

      AIM ImmunoTech Expands Patent Portfolio with New Netherlands Composition and Methods Patent Covering Ampligen for Use in the Post-COVID Condition of Fatigue

      AIM ImmunoTech Expands Patent Portfolio with New Netherlands Composition and Methods Patent Covering Ampligen for Use in the Post-COVID Condition of Fatigue OCALA, Fla., Dec. 12, 2024 (GLOBE...

      December 12 2024
      UK Regulatory

      AIM ImmunoTech Reports Positive Preliminary Data in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer

      AIM ImmunoTech Reports Positive Preliminary Data in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer Preliminary finding of stable disease in two...

      September 19 2024
      UK Regulatory

      AIM ImmunoTech to Discuss First Quarter 2024 Financial Results on May 16, 2024, and Host Conference Call and Webcast

      AIM ImmunoTech to Discuss First Quarter 2024 Financial Results on May 16, 2024, and Host Conference Call and Webcast OCALA, Fla., May 09, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE...

      May 09 2024
      UK Regulatory

      AIM ImmunoTech Completes cGMP Manufacturing of Clinical Vials of Ampligen®

      AIM ImmunoTech Completes cGMP Manufacturing of Clinical Vials of Ampligen® OCALA, Fla., May 06, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today...

      May 06 2024
      UK Regulatory

      AIM ImmunoTech Announces First Dose Level is Generally Well-Tolerated in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer

      AIM ImmunoTech Announces First Dose Level is Generally Well-Tolerated in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer Next safety cohort to...

      April 29 2024
      UK Regulatory

      AIM ImmunoTech Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian Cancer

      AIM ImmunoTech Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian Cancer OCALA, Fla...

      April 10 2024
      UK Regulatory

      AIM ImmunoTech Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

      AIM ImmunoTech Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update Year marked by growing body of promising data demonstrating Ampligen’s potential to address...

      April 02 2024
      UK Regulatory

      AIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023 Financial Results on April 2, 2024, and Host Conference Call and Webcast

      AIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023 Financial Results on April 2, 2024, and Host Conference Call and Webcast OCALA, Fla., March 26, 2024 (GLOBE NEWSWIRE) -- AIM...

      March 26 2024
      UK Regulatory

      AIM ImmunoTech Announces Publication of Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research

      AIM ImmunoTech Announces Publication of Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research Data demonstrate...

      March 25 2024
      UK Regulatory
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000DE
      40000000DE
      120000000DE
      260000000DE
      520000000DE
      1560000000DE
      2600000000DE

      0A4Y - Frequently Asked Questions (FAQ)

      What is the current Aim Immunotech share price?
      The current share price of Aim Immunotech is $ 0.00
      How many Aim Immunotech shares are in issue?
      Aim Immunotech has 48,842,000 shares in issue
      What is the 1 year trading range for Aim Immunotech share price?
      Aim Immunotech has traded in the range of $ 0.00 to $ 0.00 during the past year
      What is the PE ratio of Aim Immunotech?
      The price to earnings ratio of Aim Immunotech is -3.04
      What is the cash to sales ratio of Aim Immunotech?
      The cash to sales ratio of Aim Immunotech is 439.02
      What is the reporting currency for Aim Immunotech?
      Aim Immunotech reports financial results in USD
      What is the latest annual turnover for Aim Immunotech?
      The latest annual turnover of Aim Immunotech is USD 202k
      What is the latest annual profit for Aim Immunotech?
      The latest annual profit of Aim Immunotech is USD -28.96M
      What is the registered address of Aim Immunotech?
      The registered address for Aim Immunotech is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
      What is the Aim Immunotech website address?
      The website address for Aim Immunotech is www.aimimmuno.com
      Which industry sector does Aim Immunotech operate in?
      Aim Immunotech operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      NFXNuformix Plc
      0.115p
      (84.00%)
      		169.13M
      CHFChesterfield Resources Plc
      0.40p
      (32.45%)
      		276.93k
      IMMImmupharma Plc
      5.20p
      (28.40%)
      		49.53M
      SNGSynairgen Plc
      2.70p
      (24.14%)
      		2.31M
      GOODGood Energy Group Plc
      480.00p
      (21.52%)
      		902.4k
      DARDar Global Plc
      $ 6.00
      (-22.83%)
      		6.98k
      CLAICel Ai Plc
      0.345p
      (-21.59%)
      		28.34M
      CTAICatenai Plc
      0.21p
      (-17.65%)
      		87.41M
      GENIGenincode Plc
      4.00p
      (-16.67%)
      		1.44M
      WBIWoodbois Limited
      0.095p
      (-15.56%)
      		222.83M
      UKOGUk Oil & Gas Plc
      0.0205p
      (-4.65%)
      		802.36M
      CLONClontarf Energy Plc
      0.045p
      (12.50%)
      		689.68M
      SYMESupply@me Capital Plc
      0.0025p
      (-13.79%)
      		415.74M
      TRPTower Resources Plc
      0.0295p
      (0.00%)
      		411.68M
      NTVONativo Resources Plc
      0.0021p
      (0.00%)
      		324.32M

      Discussion

      View Full Feed
      TenKay TenKay 2 minutes ago
      No…actually true due diligence which most penny stock investors don’t understand.
      HMBL
      kund kund 2 minutes ago
      That rise was because of fomo, even anavex went up. Then everything came crashing. SAVA crashed to $10 for so many times but it was quick to recover.
      AVXL
      Mr Steele Mr Steele 4 minutes ago
      It was definitely a pump fake by VP, but maybe it's time to pay the legal team and they need $$$. If they are confident about their hand they should file immediate and full court press the defendants, they can reach a settlement at any time during a trial. This delay is not coming from a position
      VPLM
      BDEZ BDEZ 4 minutes ago
      CARTELS ARE PLANTING EXPLOSIVES ALONG THE BORDER IN PREPARATION FOR AN ALL OUT WAR

      https://x.com/MattWallace888/status/1883742057715704283
      bigstocksnbonds bigstocksnbonds 4 minutes ago
      Thanks much!!

      It's really good you're taking your lunch to work!! Those are good choices you made and YOU WILL SAVE MONEY!!💰 

      We too are trying to spend less!!

      ITS A SMART IDEA!!!💡 
      santafe2 santafe2 5 minutes ago
      i knew you would crush it today.
      Golden Cross Golden Cross 5 minutes ago
      🛫 $GRLF ~ $DBMM 000 and 00 Plays are Hot!
      DBMM GRLF
      Jimmy Joe Jimmy Joe 6 minutes ago
      10 tomorrow~? The Zoom crew better get a zoom call going at 7am. Stonk, you're in charge of the donuts. Don't be a cheapo. At least 2 dozen needed.
      Plenty of coffee too.

      Wawa running a special for rewards members. $1 coffees. My suggestion the Cuban roast extra dark, added caf
      DBMM
      kazzy kazzy 6 minutes ago
      WISON sanctions might alter the FLNG timeline.

      ZHOUSHAN WISON OFFSHORE AND MARINE CO LTD (ZHOUSHAN WISON) has built and supplied power generation modules for LLC ARCTIC LNG 2. ZHOUSHAN WISON constructed four specialized modules similar to those previously delivered to the Arctic LNG 2
      TGLO
      STL Stock STL Stock 7 minutes ago
      Some call it, grasping at straws
      HMBL
      Top Penny Top Penny 7 minutes ago
      Providence Films is getting realer by the minute/second!!! #GREATTEAM
      PSRU
      Genz2 Genz2 7 minutes ago
      https://www.axios.com/2025/01/28/trump-mike-johnson-china-deepseek-ai

      Methinks, do you think that Trump wants Steven’s thoughts on the best way to handle Trusted Computing/Wave and its benefits to the U.S’s AI and how Microsoft, Facebook, Google, NVIDIA, Intel, Open AI could have the
      DR_rugby DR_rugby 8 minutes ago
      Interesting question

      What is coming??

      https://m.youtube.com/watch?v=6UQDmlP2D7s

      Marantz Called Attny group soliciting investors to join a lawsuit against Jimmy

      But during the call they stated that they are not moving forward with the act
      GME
      BDEZ BDEZ 9 minutes ago
      Released J6 hostage gunned down in IN
      BDEZ BDEZ 10 minutes ago
      China agrees to take back their illegals living in the US after 47 threatened tariffs and sanctions.

      The art of the deal.
      EarningsCentral EarningsCentral 11 minutes ago
      SANM
      Jimmy Joe Jimmy Joe 12 minutes ago
      JEEZ. Take a pill.

      Touchy........... very touchy. And I ❤♥♥LUV♥♥❤ it~!

      Sit on it Potsy~!

      😸😆😸🤣😸😅😸😂😹😂
      LUV
      Mojocash Mojocash 12 minutes ago
      Appears like a group is running this. Volume was very low for such a quick rise. We will see tomorrow if it gaps up to the 200 MDA @.0028 and sells off the pump. I'll wait and watch for the consolidation. Time will tell...... Only took 12 million buy shares to move. Nice run so far..... kinda quick.
      DBMM
      bigrun bigrun 13 minutes ago
      What makes you say that ? Thx
      PSRU
      juicyjuice10002 juicyjuice10002 13 minutes ago
      Millions of old Americans have bought these stocks and depended upon the dividend for everyday expenses. The release will help them as well. FNMA and FMCC allowed to trade these stocks dirt cheap and now have a judgement against them for allowing NWS. There is no conflict of interest just because s
      FMCC
      PickStocks PickStocks 13 minutes ago
      The more you ask cactus aka mean girl....he deviates into more lies....it is all in the 10ks... now his claim that if the one person lost the election no distribution would happen......like the election played a factor in a distribution happening......wait for the 10k it will show 1-2 subs...a distr
      COOP
      jammy32 jammy32 15 minutes ago
      Thanks. Thoughts on today. Overreaction and we bounce back or still some down side
      NVDA
      ddls ddls 15 minutes ago
      BIEL down 20% today...Perfect!😀
      BIEL
      Joemags Joemags 16 minutes ago
      Sounds great to me!!
      I’ll have to check out the website tomorrow
      and I’ll report back
      Thanks for the update

      Your Recent History

      LSE
      0A4Y
      Aim Immunotech
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads